Skip to Content

Data and Safety Monitoring Committee

​The Data and Safety Monitoring Committee (DSMC) provides centralized review of adverse drug events and safety issues for investigator-initiated trials and NCI-funded trials. The DSMC is also charged with auditing institutional trials to ensure that the conduct and integrity of the study are of the highest quality and that all trials adhere to the regulatory requirements. Thus, all therapeutic and device investigator-initiated and NIH/NCI-funded clinical trials are monitored for scientific progress, accrual, data completeness, and regulatory compliance.

The purpose of the DSMC is to ensure:

  • The safety of clinical trial participants
  • The validity and integrity of data for all NIH-supported and investigator-initiated clinical trials
  • Compliance with NIH policy on data and safety monitoring for NIH-supported clinical trials


For more information on committee membership, meetings and the Data and Safety Monitoring Plan, log in at